[
    [
        {
            "time": "",
            "original_text": "【天风医药】智飞生物：HPV疫苗有望带动2019年全年业绩高增长",
            "features": {
                "keywords": [
                    "智飞生物",
                    "HPV疫苗",
                    "2019年",
                    "业绩高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【天风医药】智飞生物：HPV疫苗有望带动2019年全年业绩高增长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "再论医药流通！重新梳理长期医药十年十倍四大主线！【国盛医药张金洋团队】",
            "features": {
                "keywords": [
                    "医药流通",
                    "长期医药",
                    "十年十倍",
                    "四大主线"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "再论医药流通！重新梳理长期医药十年十倍四大主线！【国盛医药张金洋团队】",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医疗保健：医药行业2019Q1业绩前瞻 荐1股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "医药行业",
                    "2019Q1",
                    "业绩前瞻"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗保健：医药行业2019Q1业绩前瞻 荐1股",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]